Relmada Therapeutics, Inc. (QB)
Ticker Symbol: USOTC:RLMD
OTC Market Tier: OTCQB
CIK Number: 0001553643
Security Type: Common Stock
RLMD Address: 880 Third Avenue
12th Floor
New York, New York 10022
RLMD Country: USA
RLMD Phone: (212) 547-9591
RLMD Fax #: N/A
Description: Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company focused on the development of d-methadone (dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist as new chemical entity that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders. In addition, the Company has a portfolio of three 505b2 product candidates at various stages of development. These products are: LevoCap ER (REL-1015), an abuse resistant, sustained release dosage form of the opioid analgesic levorphanol; BuTab (oral buprenorphine, REL-1028), an oral dosage form of the opioid analgesic buprenorphine; and MepiGel (topical mepivacaine, REL-1021), an orphan drug designated topical formulation of the local anesthetic mepivacaine. These products are not currently in active development.
SIC Code / Description: 2834 / Pharmaceutical preparations
Shares Authorized: 100,000,000
Shares Outstanding: 38,974,079
Shares Outstanding Date: 09/24/2019
Shares Holder Count: 129
Shares Holder Date: 09/28/2018
Market Capitalization: $ 111,076,125.15
Key Executives: Donna Cummings - Manager, Ops.
Charles Ence - CFO
Charles Casamento - Dir.
Paul Kelly - Dir.
Maged Shenouda - Dir.
Accounts Payable - Other
Ottavio Vitolo - Chief Med. Officer
Sergio Traversa - CEO
Thomas Slusarczyk - Counsel
Number of Employees: 3
Incorporation State: NV
Incorporation Country: USA
Incorporation Year: 2012
Auditor: Marcum LLP
Auditor Address: 750 Third Ave
11th Floor
New York, NY 10017
United States
Auditor Website:
IR Firm: Life Science Advisors
IR Firm Address: N/A
IR Firm Website:
Legal Counsel: The Matt Law Firm, PLLC
Legal Counsel Address: 1701 Genesee Street
Utica, NY 13501
Legal Counsel Website: N/A
Fiscal Year End: 6/30
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: Empire Stock Transfer Inc.
TA Address: 1859 Whitney Mesa Dr.
Henderson, NV 89014
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 375,458
Short Date: 09/13/2019
Closing MMID: 12
BFCMmid: 9
Tier ID: 10
Status: Active

Your Recent History
Relmada Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.